Showing results (1811-1820 of 1,939) with videos related to

Sort By:
Pageof 194
Cerebral Circulation - Cognition and Behavior|April 13, 2026
Associations between retinal microvasculature and cognition in middle-aged adults with type 1 diabetes without overt neurological symptomsIiris Kyläheiko, Aleksi Tarkkonen, Linda Kuusela, et al.
Biomaterials|March 18, 2014
The role of integrin α2 in cell and matrix therapy that improves perfusion, viability and function of infarcted myocardiumAli Ahmadi, Brian McNeill, Branka Vulesevic, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 26, 2022
Simultaneously Enhancing Exciton/Charge Transport in Organic Solar Cells by an Organoboron AdditiveHeng Lu, Kai Chen, Raja Sekhar Bobba, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|February 11, 2023
Intensive care unit nurses' perception of three different methods for delirium screening: A survey (DELIS-3)Anne Højager Nielsen, Laura Krone Larsen, Marie Oxenbøll Collet, et al.
Iscience|March 3, 2025
Impacts of road development in sub-Saharan Africa: A call for holistic perspectives in research and policyLisa Biber-Freudenberger, Christina Bogner, Georg Bareth, et al.
International Journal of Cardiology|August 4, 2024
Impact of guideline directed medical therapy on myocardial function in adults with congenital heart diseaseCarley Bright, Afshan Rizvi, Francis Ezekwueme, et al.
JAMA Internal Medicine|July 27, 2026
High-Efficiency Particulate Air Filters to Prevent Winter Respiratory Infections in Care Homes: The AFRI-c Cluster Randomized Clinical TrialAlastair D Hay, Rachel C M Brierley, Nick Turner, et al.
Nature Communications|May 20, 2022
Free charge photogeneration in a single component high photovoltaic efficiency organic semiconductorMichael B Price, Paul A Hume, Aleksandra Ilina, et al.
The Lancet. Infectious Diseases|May 9, 2026
Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trialNatasha Thorn, Zsofia Danos, Nick J Andrews, et al.
Lung Cancer (Amsterdam, Netherlands)|August 29, 2006
A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinomaHelen J Ross, Lowell L Hart, Paul M Swanson, et al.
Pageof 194